Literature DB >> 22271964

Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries.

Antonio Lora1, Robert Kohn, Itzhak Levav, Ryan McBain, Jodi Morris, Shekhar Saxena.   

Abstract

OBJECTIVE: To outline mental health service accessibility, estimate the treatment gap and describe service utilization for people with schizophrenic disorders in 50 low- and middle-income countries.
METHODS: The World Health Organization Assessment Instrument for Mental Health Systems was used to assess the accessibility of mental health services for schizophrenic disorders and their utilization. The treatment gap measurement was based on the number of cases treated per 100,000 persons with schizophrenic disorders, and it was compared with subregional estimates based on the Global burden of disease 2004 update report. Multivariate analysis using backward step-wise regression was performed to assess predictors of accessibility, treatment gap and service utilization.
FINDINGS: The median annual rate of treatment for schizophrenic disorders in mental health services was 128 cases per 100,000 population. The median treatment gap was 69% and was higher in participating low-income countries (89%) than in lower-middle-income and upper-middle-income countries (69% and 63%, respectively). Of the people with schizophrenic disorders, 80% were treated in outpatient facilities. The availability of psychiatrists and nurses in mental health facilities was found to be a significant predictor of service accessibility and treatment gap.
CONCLUSION: The treatment gap for schizophrenic disorders in the 50 low- and middle-income countries in this study is disconcertingly large and outpatient facilities bear the major burden of care. The significant predictors found suggest an avenue for improving care in these countries.

Entities:  

Mesh:

Year:  2011        PMID: 22271964      PMCID: PMC3260570          DOI: 10.2471/BLT.11.089284

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  WHO's Assessment Instrument for Mental Health Systems: collecting essential information for policy and service delivery.

Authors:  Shekhar Saxena; Antonio Lora; Mark van Ommeren; Thomas Barrett; Jodi Morris; Benedetto Saraceno
Journal:  Psychiatr Serv       Date:  2007-06       Impact factor: 3.084

Review 2.  The burden of mental disorders.

Authors:  William W Eaton; Silvia S Martins; Gerald Nestadt; O Joseph Bienvenu; Diana Clarke; Pierre Alexandre
Journal:  Epidemiol Rev       Date:  2008-09-19       Impact factor: 6.222

3.  An overview of the mental health system in Italy.

Authors:  Antonio Lora
Journal:  Ann Ist Super Sanita       Date:  2009       Impact factor: 1.663

4.  Mental health services in 42 low- and middle-income countries: a WHO-AIMS cross-national analysis.

Authors:  Shekhar Saxena; Antonio Lora; Jodi Morris; Annamaria Berrino; Patricia Esparza; Thomas Barrett; Mark van Ommeren; Benedetto Saraceno
Journal:  Psychiatr Serv       Date:  2011-02       Impact factor: 3.084

5.  The mental health workforce gap in low- and middle-income countries: a needs-based approach.

Authors:  Tim A Bruckner; Richard M Scheffler; Gordon Shen; Jangho Yoon; Dan Chisholm; Jodi Morris; Brent D Fulton; Mario R Dal Poz; Shekhar Saxena
Journal:  Bull World Health Organ       Date:  2010-11-22       Impact factor: 9.408

Review 6.  The treatment gap in mental health care.

Authors:  Robert Kohn; Shekhar Saxena; Itzhak Levav; Benedetto Saraceno
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

7.  Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis.

Authors:  Dan Chisholm; Oye Gureje; Sandra Saldivia; Marcelo Villalón Calderón; Rajitha Wickremasinghe; Nalaka Mendis; Jose-Luis Ayuso-Mateos; Shekhar Saxena
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408

Review 8.  A systematic review of the prevalence of schizophrenia.

Authors:  Sukanta Saha; David Chant; Joy Welham; John McGrath
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

  8 in total
  49 in total

Review 1.  Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies.

Authors:  Jair de Jesus Mari; Luís Fernando Tófoli; Cristiano Noto; Li M Li; Alessandra Diehl; Angélica M Claudino; Mario F Juruena
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

2.  Public health and physician focused strategies to improve medication adherence in psychotic disorders.

Authors:  Saeed Farooq
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

Review 3.  Challenges and Opportunities in Global Mental Health: a Research-to-Practice Perspective.

Authors:  Milton L Wainberg; Pamela Scorza; James M Shultz; Liat Helpman; Jennifer J Mootz; Karen A Johnson; Yuval Neria; Jean-Marie E Bradford; Maria A Oquendo; Melissa R Arbuckle
Journal:  Curr Psychiatry Rep       Date:  2017-05       Impact factor: 5.285

Review 4.  Brave new worlds--review and update on virtual reality assessment and treatment in psychosis.

Authors:  Wim Veling; Steffen Moritz; Mark van der Gaag
Journal:  Schizophr Bull       Date:  2014-09-05       Impact factor: 9.306

5.  Care gap: a comprehensive measure to quantify unmet needs in mental health.

Authors:  S Pathare; A Brazinova; I Levav
Journal:  Epidemiol Psychiatr Sci       Date:  2018-03-09       Impact factor: 6.892

6.  Technology-based interventions for psychiatric illnesses: improving care, one patient at a time.

Authors:  D Ben-Zeev
Journal:  Epidemiol Psychiatr Sci       Date:  2014-07-21       Impact factor: 6.892

7.  Symptoms of Depression, Positive Symptoms of Psychosis, and Suicidal Ideation Among Adults Diagnosed With Schizophrenia Within the Clinical Antipsychotic Trials of Intervention Effectiveness.

Authors:  Lindsay A Bornheimer; James Jaccard
Journal:  Arch Suicide Res       Date:  2016-08-23

8.  The relationships between patients' and caregivers' beliefs about the causes of schizophrenia and clinical outcomes in Latin American countries.

Authors:  Alejandra Caqueo-Urízar; Laurent Boyer; Karine Baumstarck; Stephen E Gilman
Journal:  Psychiatry Res       Date:  2015-06-29       Impact factor: 3.222

9.  Proposed Training Areas for Global Mental Health Researchers.

Authors:  Lauren C Ng; Jessica F Magidson; Rebecca S Hock; John A Joska; Abebaw Fekadu; Charlotte Hanlon; Janina R Galler; Steven A Safren; Christina P C Borba; Gregory L Fricchione; David C Henderson
Journal:  Acad Psychiatry       Date:  2016-03-14

Review 10.  Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016.

Authors:  Fiona J Charlson; Alize J Ferrari; Damian F Santomauro; Sandra Diminic; Emily Stockings; James G Scott; John J McGrath; Harvey A Whiteford
Journal:  Schizophr Bull       Date:  2018-10-17       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.